- GLYC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
GlycoMimetics (GLYC) CORRESPCorrespondence with SEC
Filed: 5 Oct 17, 12:00am
October 5, 2017
VIA EDGAR
Mr. Christopher Edwards
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: GlycoMimetics, Inc. (the “Registrant”)
Registration Statement on Form S-3, File No. 333-220697
Acceleration Request
Requested Date: Friday, October 6, 2017
Requested Time: 4:00 p.m. Eastern Time
Dear Mr. Edwards:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-220697) (the “Registration Statement”) to become effective on Friday, October 6, 2017, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).
Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Mark Ballantyne at (703) 456-8084.
| Very truly yours, | ||
|
| ||
| GLYCOMIMETICS, INC. | ||
|
| ||
| By: | /s/ Brian M. Hahn | |
|
| Brian M. Hahn | |
|
| Chief Financial Officer | |
|
| ||
cc: | Brent B. Siler, Cooley LLP |
| |
| Brian F. Leaf, Cooley LLP |
|